Cargando…
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease
Over the decades, pharmaceutical treatments, particularly dopaminergic (DAergic) drugs have been considered as the main therapy against motor symptoms of Parkinson's disease (PD). It is proposed that DAergic drugs in combination with other medications, such as monoamine oxidase type B inhibitor...
Autores principales: | Dong, Jie, Cui, Yanhua, Li, Song, Le, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876590/ https://www.ncbi.nlm.nih.gov/pubmed/26585523 http://dx.doi.org/10.2174/1570159X14666151120123025 |
Ejemplares similares
-
Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker
por: Yang, Zhaofei, et al.
Publicado: (2019) -
Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson’s disease
por: Li, Tianbai, et al.
Publicado: (2020) -
Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms
por: Pucelik, Barbara, et al.
Publicado: (2022) -
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
por: Pardo-Moreno, Teresa, et al.
Publicado: (2023) -
Investigation of the Pharmaceutical Care in One Elderly Parkinson’s Disease Patient with Psychotic Symptoms
por: Gu, Chun-Ping, et al.
Publicado: (2018)